l‐Asparaginase (a hydrolase converting l‐asparagine to l‐aspartic acid) was the first
enzyme to be used in clinical practice as an anticancer agent after its approval in 1978 as a …

In the past decades, the production of biopharmaceuticals has gained high interest due to its
great sensitivity, specificity, and lower risk of negative effects to patients. Biopharmaceuticals …

L-asparaginase is an enzyme that catalyzes the degradation of asparagine and successfully
used in the treatment of acute lymphoblastic leukemia. L-asparaginase toxicity is either …

The current pandemic of Covid-19 caused by SARS-CoV-2 is continued to spread globally
and no potential drug or vaccine against it is available. Spike (S) glycoprotein is the …

L-asparaginases (EC 3.5. 1.1) are a family of enzymes that catalyze the hydrolysis of L-
asparagine to L-aspartic acid and ammonia. These proteins with different biochemical …

To date, the current COVID-19 pandemic caused by SARS-CoV-2 has infected 99.2 million
while killed 2.2 million people throughout the world and is still spreading widely. The …

Type II L-asparaginase as a pivotal enzyme agent has been applied to treating for acute
lymphoblastic leukemia (ALL) and efficient mitigation of acrylamide formed in fried and …

Bacterial L-asparaginase is the key therapeutic enzyme in cancer therapy and is also
witnessing demand as a food processing aid. In this study, L-asparaginase of newly isolated …

Asparagine, an important amino acid in mammals, is produced in several organs and is
widely used for the production of other nutrients such as glucose, proteins, lipids, and …

L-asparaginase is an important industrial enzyme widely used to treat acute lymphoblastic
leukemia (ALL) and to reduce acrylamide formation in food products. In the current study, a …